Issue 7, 2007

Fingerprinting a killer: surveillance of the influenza virus by mass spectrometry

Abstract

Influenza is a deadly virus that continues to kill and inflict illness and suffering the world over. Despite a global surveillance strategy, an annual response to vaccine preparation and the development of new anti-viral drugs to treat the virus ahead of, or after, infection, no cure exists. Future pandemics are a very real threat and countries have mobilised efforts to stockpile treatments and prepare for outbreaks. A new surveillance approach in which the structure and antigenicity of the virus can be rapidly screened by mass spectrometry is expected to have a greater role in the characterisation of emerging influenza strains, even at the site of an outbreak.

Graphical abstract: Fingerprinting a killer: surveillance of the influenza virus by mass spectrometry

Article information

Article type
Highlight
First published
01 May 2007

Analyst, 2007,132, 611-614

Fingerprinting a killer: surveillance of the influenza virus by mass spectrometry

K. M. Downard and B. Morrissey, Analyst, 2007, 132, 611 DOI: 10.1039/B701835E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements